PATENT CLAIM ANALYSIS

Application Number: 15891118
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["514", "04400A"]

Abstract:
Provided herein are oligomeric compounds with conjugate groups targeting apolipoprotein C-III (ApoCIII). In certain embodiments, the ApoCIII targeting oligomeric compounds are conjugated to N-Acetylgalactosamine. Also disclosed herein are conjugated oligomeric compounds targeting ApoCIII for use in decreasing ApoCIII to treat, prevent, or ameliorate diseases, disorders or conditions related to ApoCIII. Certain diseases, disorders or conditions related to ApoCIII include inflammatory, cardiovascular and/or metabolic diseases, disorders or conditions. The conjugated oligomeric compounds disclosed herein can be used to treat such diseases, disorders or conditions in an individual in need thereof.

Claim (Index 43):
The compound of  claim 26 , wherein the conjugate linker has a structure selected from among:

Metadata:
- Claim Count in Document: 59.0
- Percentile: 88.0
- Lexical Diversity: 2.0
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14586826', '14839580', '14588061', '14959714', '14701999']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9234397553436572
- 35 USC 102 Novelty (BERT): 0.6901562201406547
- Combined Prediction Score: 0.9001114018233571
- Mean Citation Score: 940.98746
- Max Citation Score: 996.7765
- Similarity Product: 705.4188025313914

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test